Kincell Bio (Series A)

Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
May 26, 2025
Vertical
Healthcare
Funding URL
View Funding Page
Funding Amount:
$22,000,000

Company Info
Company Description
Kincell Bio engineers cells into therapies. It is a contract development and manufacturing organization (CDMO) focused on supporting innovative companies developing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK and CAR-M programs.
Market
Contract Development and Manufacturing Organization (CDMO)
Location
Research Triangle Park, North Carolina, USA
Coinvestors
NewSpring Capital, Kineticos Life Sciences

Links